US Edition
News from Pharmacy Times
We’ve assigned a rating of Unknown factuality to Pharmacy Times. You can read more about how we’ve determined Pharmacy Times’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmacy Times News
Measles · United StatesA school-age child has died from a rare complication of measles contracted in infancy, Los Angeles County health officials said Thursday. The child, who had been too young to be vaccinated when they were infected by the virus, died of subacute sclerosing panencephalitis, according to the county health department. The incurable disorder causes progressive brain damage and is nearly universally fatal. About 1 in 10,000 people who get measles devel…See the Story
Child Dies From Complication of Measles Contracted Years Earlier
66% Center coverage: 65 sources
FDA · United StatesMONDAY, Sept. 8, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved expanded use of Vonvendi (von Willebrand factor [recombinant]) for routine prophylactic use in adults with all types of the blood-clotting disorder von Willebrand disease (VWD),…See the Story
FDA Expands Use of Vonvendi for Von Willebrand Disease
45% Center coverage: 18 sources
El Paso · El PasoTHURSDAY, Sept. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.See the Story
FDA Approves Inlexzo for Bladder Cancer
55% Center coverage: 11 sources
